
Healthcare companies are among the riskiest to invest in because of the potential for failure and market disruptions. However, they can also provide attractive returns—if you pick the right ones. Insider buying is no guarantee that a healthcare company will deliver explosive results, but it does help. This is a look at three healthcare companies whose insiders are buying, and not just because they want to support the stock’s price.
These companies all have the potential to deliver for investors through their therapies and to impact global health outcomes.